Literature DB >> 2669471

Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group.

A Muñoz1, M C Wang, S Bass, J M Taylor, L A Kingsley, J S Chmiel, B F Polk.   

Abstract

To estimate the time interval between human immunodeficiency virus type 1 (HIV-1) seroconversion and acquired immunodeficiency syndrome (AIDS) diagnosis in homosexual men, prospective incident cohorts are difficult to obtain and, if assembled, provide few events owing to the long incubation time. Although seroprevalent cohorts are numerous in size and events, the information is limited due to the unknown times since seroconversion. To combine the information provided by 1,628 seroprevalent men (304 AIDS cases) and 233 seroconverters (12 AIDS cases) being followed in a multicenter study since 1984, the postseroconversion changes in hematologic variables occurring in the incident cohort were used to develop a model that allowed for the imputation of the unknown times since seroconversion for the seroprevalent cohort. Nonparametric life table methods incorporating truncation and censoring were applied for the estimation of the probability distribution of the AIDS-free time after seroconversion. The precision of the estimates was evaluated using bootstrap methods. The analysis suggested that AIDS is unlikely (less than 0.5%) in the first year; 78% of seropositive homosexual men remain AIDS-free 60 months after seroconversion; and the AIDS incidence increases for months 12-36 and levels off at 38 per 1,000 person-semesters for months 42-60. The nonparametric estimate of the incidence rate suggests a median AIDS-free time of 11 years, which is longer than previous estimates based on parametric models.

Entities:  

Mesh:

Year:  1989        PMID: 2669471     DOI: 10.1093/oxfordjournals.aje.a115367

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  38 in total

1.  Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia.

Authors:  Frederik Graw; Thomas Leitner; Ruy M Ribeiro
Journal:  Epidemics       Date:  2012-05-02       Impact factor: 4.396

2.  Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis.

Authors:  Q X Hu; A P Barry; Z X Wang; S M Connolly; S C Peiper; M L Greenberg
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 3.  Progression of HIV-infection: markers or determinants.

Authors:  J P Phair; H Farzadegan; J Chmiel; A Muñoz; R Detels; A Saah; R Kaslow
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

4.  New York State HIV seroprevalence project: goals, windows, and policy consideration.

Authors:  L F Novick
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

5.  Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.

Authors:  G W Rutherford; A R Lifson; N A Hessol; W W Darrow; P M O'Malley; S P Buchbinder; J L Barnhart; T W Bodecker; L Cannon; L S Doll
Journal:  BMJ       Date:  1990-11-24

6.  HIV instruction, HIV knowledge, and drug injection among high school students in the United States.

Authors:  D Holtzman; J E Anderson; L Kann; S L Arday; B I Truman; L J Kolbe
Journal:  Am J Public Health       Date:  1991-12       Impact factor: 9.308

7.  Marker processes in survival analysis.

Authors:  N P Jewell; J D Kalbfleisch
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

8.  Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression.

Authors:  Daniel T Claiborne; Jessica L Prince; Eileen Scully; Gladys Macharia; Luca Micci; Benton Lawson; Jakub Kopycinski; Martin J Deymier; Thomas H Vanderford; Krystelle Nganou-Makamdop; Zachary Ende; Kelsie Brooks; Jianming Tang; Tianwei Yu; Shabir Lakhi; William Kilembe; Guido Silvestri; Daniel Douek; Paul A Goepfert; Matthew A Price; Susan A Allen; Mirko Paiardini; Marcus Altfeld; Jill Gilmour; Eric Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

9.  How fast could HIV change gene frequencies in the human population?

Authors:  Deborah Cromer; Steven M Wolinsky; Angela R McLean
Journal:  Proc Biol Sci       Date:  2010-03-10       Impact factor: 5.349

10.  Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis.

Authors:  Afam Okoye; Haesun Park; Mukta Rohankhedkar; Lia Coyne-Johnson; Richard Lum; Joshua M Walker; Shannon L Planer; Alfred W Legasse; Andrew W Sylwester; Michael Piatak; Jeffrey D Lifson; Donald L Sodora; Francois Villinger; Michael K Axthelm; Joern E Schmitz; Louis J Picker
Journal:  J Exp Med       Date:  2009-06-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.